Granahan Investment Management, LLC Ligand Pharmaceuticals Inc Transaction History

Granahan Investment Management, LLC

$2.39 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $675,374 - $1.06 Million	-9,063 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $5.71 Million - $9.11 Million	-60,078 Reduced 86.89%	9,063 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $6.12 Million - $7.94 Million	-47,892 Reduced 40.92%	69,141 $10.7 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $4.66 Million - $6.59 Million	-45,532 Reduced 28.01%	117,033 $16.3 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $9.93 Million - $13.7 Million	-87,871 Reduced 35.09%	162,565 $21.3 Million
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $5.68 Million - $12.3 Million	57,097 Added 29.53%	250,436 $38.2 Million
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $8.5 Million - $11.2 Million	105,516 Added 120.15%	193,339 $19.2 Million
Q3 2020 Nov 12, 2020	BUY	$89.56 - $126.72 $3.67 Million - $5.19 Million	40,945 Added 87.34%	87,823 $8.37 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $248,266 - $449,591	-3,636 Reduced 7.2%	46,878 $5.24 Million
Q1 2020 May 12, 2020	BUY	$63.37 - $107.88 $2.45 Million - $4.16 Million	38,593 Added 323.74%	50,514 $3.67 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $837,076 - $980,849	-8,635 Reduced 42.01%	11,921 $1.24 Million
Q3 2019 Nov 15, 2019	BUY	$86.25 - $120.16 $260,043 - $362,282	3,015 Added 17.19%	20,556 $2.05 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $1.78 Million - $2.14 Million	-16,533 Reduced 48.52%	17,541 $2 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $4.03 Million - $5.42 Million	-38,051 Reduced 52.76%	34,074 $4.28 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $5.93 Million - $12.6 Million	46,236 Added 178.59%	72,125 $9.79 Million
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $1.69 Million - $2.19 Million	7,994 Added 44.67%	25,889 $7.11 Million
Q2 2018 Aug 15, 2018	SELL	$150.77 - $207.98 $2.36 Million - $3.25 Million	-15,638 Reduced 46.63%	17,895 $3.71 Million
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $742,502 - $978,112	-5,356 Reduced 13.77%	33,533 $5.54 Million
Q4 2017 Feb 12, 2018	BUY	$128.36 - $147.04 $464,278 - $531,843	3,617 Added 10.25%	38,889 $5.33 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $4.26 Million - $4.87 Million	35,272	35,272 $4.8 Million

Others Institutions Holding LGND

# of Institutions

247

Shares Held

17.5M

Call Options Held

61K

Put Options Held

7.8K

Black Rock Inc. New York, NY

2.87M
Shares

$280 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.93M
Shares

$188 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

1.01M
Shares

$98.2 Million
0.05% of portfolio
Macquarie Group LTD Australia, C3

967K
Shares

$94.1 Million
0.1% of portfolio
Dimensional Fund Advisors LP Austin, TX

709K
Shares

$69 Million
0.02% of portfolio

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.64B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account